Meet and ask questions to CEO, Peter Zerhouni, when he gives an introduction to their company.

InDex Pharmaceuticals is a Swedish pharmaceutical company seeking to improve the lives of patients suffering from immunological diseases. The company's mission is to develop effective and safe drugs for diseases with a significant medical need. Their current focus is ulcerative colitis, a chronic and debilitating inflammation of the large intestine that affects patients of all ages, though it is most commonly diagnosed when patients are 15-30 years old.

Hear more about InDex Pharmaceuticals in this event.